E2F1 and breast carcinoma: Indeed, using the logic model of core circuits, Khan et al (102) identified several EMT receptor proteins that, in combination with E2F1 upregulation, could be regarded as more reliable biomarkers for predicting the malignant progression of bladder cancer and breast cancer.